Cytochrome P450 2C is an EDHF synthase in coronary arteries

Nature

Volumn 401, Issue 6752, 1999, Pages 493-497

  Fissithaler, Beate ^a   Popp, Rüdiger ^a   Kiss, Ladislau ^b   Potente, Michael ^a   Harder, David R ^c   Fleming, Ingrid ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NAPHTHOFLAVONE; CYTOCHROME P450; DICLOFENAC; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ICOSATETRAENOIC ACID; MESSENGER RNA; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CORONARY ARTERY; ELECTROPHYSIOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; VASCULAR ENDOTHELIUM; VASODILATATION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONIC ACID; BIOLOGICAL FACTORS; BRADYKININ; CELLS, CULTURED; CORONARY VESSELS; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; OXYGENASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; VASODILATION;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0033619262     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/46816     Document Type: Article

References (22)

1. Rubanyi, G. M. & Vanhoutte, P. M. Nature of endothelium-derived relaxing factor: are there two relaxing mediators? Circ. Res. 61, SII-61-SII-67 (1987).
2. Chen, G., Suzuki, H. & Weston, A. H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95, 1165-1174 (1988).
3. Quilley, J., Fulton, D. & McGiff, J. C. Hyperpolarizing factors, Biochem. Pharmacol. 54, 1059-1070 (1997).
4. + channels. Circ. Res. 83, 501-307 (1998).
5. Hecker, M., Bara, A. T., Bauersachs, J. & Busse, R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. (Lond.) 481, 407-414 (1994).
6. Popp, R. et al. A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J. Physiol. (Lond.) 497, 699-709 (1996).
7. 2 and epoxyeicosatrienic acids in relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol. 264, H327-H335 (1993).
8. Pinto, A., Abraham, N. G. & Mullane, K. M. Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450 dependent pathway. J. Pharmacol. Exp. Ther. 240, 856-882 (1987).
9. Oltman, C. L., Weintraub, N. L., VanRollins, M. & Dellsperger, K. C. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ. Res. 83, 932-939 (1998).
10. Fulton, D., Mahboubi, K., McGiff, J. C. & Quilley, J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114, 99-102 (1995).
11. Bauersachs, J., Hecker, M. & Busse, R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol. 113, 1548-1553 (1994).
12. Campbell, W. B., Gebremedhin, D., Pratt, P. F. & Harder, D. R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78, 415-423 (1996).
13. Komori, K. & Vanhoutte, P. M. Endothelium-derived hyperpolarizing factor. Blood Vessels 27, 238-245 (1990).
14. 2+ influx. Biochem. J. 274, 193-197 (1991).
15. + channels by cytochrome P-450 inhibitors, J. Biol. Chem. 267, 11789-11793 (1992).
16. Guengerich, F. P. Characterization of human cytochrome P450 enzymes. FASEB J. 6, 745-748 (1992).
17. Mancy, A. et al. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry 35, 16205-16212 (1996).
18. Kiss, L. et al. Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P450 products from different biological sources by reversed-phase high-performance liquid Chromatographic technique. Anal. Biochem. 261, 16-28 (1998).
19. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396, 269-272 (1998).
20. Pritchard, K. A. Jr, Wong, P. & Stemerman, M. B. Atherogenic concentrations of low density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products. Am. J. Pathol. 136, 1381-1391 (1990).
21. Puntarulo, S. & Cederbaum, A. I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radical Biol. Med. 24, 1324-1330 (1998).
22. Bauersachs, J. et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94, 3341-3347 (1996).